Clinical Research Directory
Browse clinical research sites, groups, and studies.
FDG PET/MR Imaging of Peripheral Pain Generators
Sponsor: University of Wisconsin, Madison
Summary
The purpose of this research is to determine if a PET/MRI scan using FDG can accurately identify the source of chronic pain. Identifying the source of pain may help doctors treat chronic pain more effectively. Approximately 128 participants will be enrolled and can expect to be on study for up to 12 months.
Official title: FDG PET/MR Imaging of Peripheral Pain Generators in Persistent Post-Surgical Pain (PPSP)
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
128
Start Date
2024-11-19
Completion Date
2027-06
Last Updated
2025-09-25
Healthy Volunteers
Yes
Conditions
Interventions
FDG radiotracer
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-\[18F\]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection. Dosage planned 0.14 mCi/kg/patient.
PET/MRI
positron emission tomography and magnetic resonance imaging
PET/CT imaging
positron emission tomography and computed tomography imaging
Locations (1)
UW School of Medicine and Public Health
Madison, Wisconsin, United States